Agenda1 Analytical Services Ltd (Now Concept Life Sciences)

Ajinomoto OmniChem is a Belgian company that has been active in developing and producing Fine Chemicals for the pharmaceutical field for more than 25 years. During the last 15 years, the average growth of the company has been of +7%. With about 700 people located in Belgium on 3 sites complying all cGMP and FDA certification (Louvain-La-Neuve, Wetteren, Balen), AjinomotoOmniChem positions itself as a leader in the Pharmaceutical Fine Chemicals Industry.

OmniChem's main activity is to develop and manufacture pharmaceutical fine chemicals.

Ajinomoto OmniChem consists of 2 divisions: OmniChem (OCD) and AminoScience (ASD).

OmniChem division (OCD) is divided into 3 business units: Pharmaceutical Fine Chemicals (PFC's), Tensiofix and NaturalSpecialities.

More information can be found on the respective websites ie:
www.omnichem.be
www.natural-specialities.com
www.tensiofix.com

Today's Euticals is one of the leading players in the pharmaceutical & fine chemicals industry with a global scale production and diversified manufacturing sites. All plants, located in Italy, France, Germany and USA are usually inspected by international and national regulatory agencies, such as FDA (acceptable with no 483), KFDA, ANVISA, etc.

Banking on, also, the last acquisitions, Poli-Industria Chimica in 2010 and Archimica in 2011, Euticals purpose is to be the ideal partner for pharmaceutical and chemical companies satisfying any inquiry, coming from the API generic market and pharmaceutical research companies, covering the worldwide area. The strategic proposition is to develop innovative solutions and ensure high quality and competitive prices by continuously improving every process and manufacturing activity.

Fine Organics, a Lianhe Chemical Technology business, is a leading European contract manufacturer of high quality fine chemicals for use in the Crop Protection, Pharmaceutical and Performance chemicals markets.

Usually working from a process package provided by a client, our skills and experience are applied to finding solutions which will enable safe production, deliver yield and quality performance while minimising the requirement for plant investment and so shortening the lead time to first production.

All our business is conducted under secrecy agreement.
• 376m3 of multipurpose glass lined and Hastelloy reactor capacity
• Sited in the Seal Sands Chemical Park – excellent and extensive support infrastructure
• COMAH (SEVESO III) top tier site
• Broad Hazardous substance Consent
• Flexible environmental permit operating under a multi-product protocol
• ISO 9001, ISO 14001, OHSAS 180001 and Responsible Care accredited
• US FDA Inspected in February 2017 for cGMP manufacture

For more information please refer to our website.

Our Commercial Team is:

For Pharmaceuticals and Performance Chemicals

James Rankin
Commercial Director
Telephone +44 (0)1642 694205
Fax +44 (0)1642 546046

For Agrochemicals

Simon Rowell
Commercial Director
Telephone +44 (0)1642 694251
Fax +44 (0)1642 546046

Head Office
Telephone +44 (0)1642 546666
Fax +44 (0)1642546046

PhosphonicS is a global company with its Headquarters in the UK and is passionate about maximising the potential returns from precious metals.

At PhosphonicS we deliver simple, fast and effective solutions to complex problems using a customer-focused approach. We enable companies across many industries to maximise their potential returns using our patented functionalised silica technology. If you have a problem removing an impurity from a fine chemical or pharmaceutical ingredient, or want to recover the value from precious metals in your process, in an environmentally sustainable manner, please visit our website at www.phosphonics.com

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology